Showing 5,201 - 5,220 results of 27,164 for search '(( 50 ((mean decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 teer decrease ))', query time: 0.97s Refine Results
  1. 5201

    Bar graph showing proportion of NADCs. by Raymond Atwine (18574812)

    Published 2025
    “…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  2. 5202

    Baseline characteristics of study participants. by Raymond Atwine (18574812)

    Published 2025
    “…The Commonest ADC was Kaposi Sarcoma (KS) while the commonest NADC was Squamous cell carcinoma, Not otherwise specified. Age above 50 years was associated with a significantly reduced risk of ADCs (OR: 0.11; 95% CI: 0.03–0.43; p value: 0.002). …”
  3. 5203

    S1 Data - by Shane R. McClafferty (19434460)

    Published 2024
    “…Once pups had reached adolescence (PND 50), researchers tested for differences in anxiety, activity, and social behavior using elevated plus-maze, open field habituation, a three-chamber social interaction, and a social discrimination task. …”
  4. 5204
  5. 5205
  6. 5206
  7. 5207
  8. 5208

    S4 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  9. 5209

    S6 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  10. 5210

    S3 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  11. 5211

    S9 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  12. 5212

    S7 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  13. 5213

    S1 Raw data - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  14. 5214

    S8 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  15. 5215

    S2 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  16. 5216

    S1 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  17. 5217

    S5 Fig - by Jian Zhong (329110)

    Published 2024
    “…Juglone inhibited LLC and A549 cells viability, with IC50 values of 10.78 μM and 9.47 μM, respectively, for 24 h, and substantially suppressed the migration and invasion of these two lung cancer cells. …”
  18. 5218
  19. 5219
  20. 5220